Today, ensuring innovation remains accessible is paramount. We are now able to deliver therapies like CAR-T at 5–8% of the cost compared to the U.S., without compromising on quality or outcomes. Currently, India’s strategic investments in local manuf

Viren Shetty, Executive Vice Chairman of Narayana Health, emphasized that drugs alone cannot transform outcomes—India needs integration between hospitals, insurers, and pharma to ensure innovation reaches patients at scale.

In an interaction with Thiruamuthan, Correspondent, India Pharma Outlook, Anjali Ajaikumar, Director, Milann Fertility & Birthing Hospital, discusses the rising infertility challenge, evolving fertility treatments, and innovations shaping personalize

In an exclusive interview with Thiruamuthan, Correspondent at India Pharma Outlook, Aditya Sharma, Head of Process Solutions, India Region, Merck Life Science, discusses how a dedicated formulation and technology centre addresses complex challenges i

In an interaction with India Pharma Outlook, Deepak Ghagare, Associate Director SBS, Spectrum Pharmatech shares insights on India’s evolving HPAPI manufacturing landscape, emphasizing advanced containment strategies and regulatory alignment.

A few months ago, I came across the story of an Indian pharmaceutical exporter whose shipment to the US market was rejected at the port. This rejection had nothing to do with product formulation or its manufacturing and safety process...